Viewing Study NCT01705392


Ignite Creation Date: 2025-12-24 @ 3:58 PM
Ignite Modification Date: 2026-02-06 @ 11:57 AM
Study NCT ID: NCT01705392
Status: TERMINATED
Last Update Posted: 2017-02-24
First Post: 2012-10-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Bevacizumab vs Dacarbazine in Metastatic Melanoma
Sponsor: Haukeland University Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Malignant Melanoma View
None Unresectable Malignant Melanoma View
Keywords: